Halozyme Therapeutics
HALO
#2112
Rank
A$11.68 B
Marketcap
$94.86
Share price
1.04%
Change (1 day)
49.41%
Change (1 year)

Halozyme Therapeutics (HALO) - Total debt

Total debt on the balance sheet as of December 2024 : A$2.37 Billion

According to Halozyme Therapeutics's latest financial reports the company's total debt is A$2.37 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Halozyme Therapeutics - Total debt on balance sheet (from 2011 to 2024)

Total debt by year

Year Total debt Change
2023-12-31A$2.20 B-0.57%
2022-12-31A$2.21 B83.03%
2021-12-31A$1.20 B134.08%
2020-12-31A$0.51 B-10.16%
2019-12-31A$0.57 B220.52%
2018-12-31A$0.17 B-30.79%
2017-12-31A$0.25 B-13.75%
2016-12-31A$0.30 B339.32%
2015-12-31A$68.4 M12.28%
2014-12-31A$60.92 M9.18%
2013-12-31A$55.79 M86.38%
2012-12-31A$29.93 M
2011-12-31N/A

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
A$0.37 B-84.04%๐Ÿ‡บ๐Ÿ‡ธ USA
A$53.05 B 2,134.31%๐Ÿ‡บ๐Ÿ‡ธ USA
A$20.80 B 776.21%๐Ÿ‡บ๐Ÿ‡ธ USA
A$105.05 B 4,324.03%๐Ÿ‡บ๐Ÿ‡ธ USA
A$29.38 B 1,137.44%๐Ÿ‡ซ๐Ÿ‡ท France
A$57.77 B 2,332.86%๐Ÿ‡บ๐Ÿ‡ธ USA